129
Participants
Start Date
January 8, 2021
Primary Completion Date
February 18, 2025
Study Completion Date
December 2, 2025
Bedaquiline
Participants will receive BDQ tablets only/
Clarithromycin
Participants will receive CAM 400 or 500 mg twice a day.
Ethambutol
Participants will receive 500 to 750 mg daily (maximum daily dose of 1.0 gram \[g\]) or 15 mg/kg once a day.
Rifampicin
Participants will receive daily dose is 450 mg (maximum 600 mg) RFP capsule once a day.
Rifabutin
Participants will receive daily dose of RBT 300 mg or 150 mg capsules once a day.
Taipei Veterans General Hospital, Taipei
National Taiwan University Hospital, Taipei
Taichung Veterans General Hospital, Taichung
Chonnam National University Hospital, Gwangju
Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung City
Fukuoka University Chikushi Hospital, Chikushino-shi
St. Luke's International Hospital, Chūōku
Fukui Prefectural Hospital, Fukui-shi
National Hospital Organization Ibarakihigashi, Funaishikawa
Gifu Prefectural General Medical Center, Gifu
Hamamatsu Rosai Hospital, Hamamatsu
Seirei Hamamatsu General Hospital, Hamamatsu
National Hospital Organization Tenryu Hospital, Hamamatue
Matsunami General Hospital, Hashima-gun
Matsunami Health Promotion Clinic, Hashimagun Kasamatsucho
National Hospital Organization Himeji Medical Center, Himeji
Saitama Medical University Hospital, Iruma-gun
National Hospital Organization Minami Kyoto Hospital, Jōyō
Fukujuji Hospital, Kiyose
Kobe City Medical Center West Hospital, Kobe Nagata-Ku
National Hospital Organization Kochi National Hospital, Kochi
National Hospital Organization Fukuoka Higashi Medical Center, Koga
Saitama Prefectural Cardiovascular and Respiratory Center, Kumagaya
Rakuwakai Otowa Hospital, Kyoto
National Hospital Organization Kyoto Medical Center, Kyoto
Matsusaka Municipal Hospital, Matsusaka
Musashino Red Cross Hospital, Musashino
Nagaoka Red Cross Hospital, Nagaoka
Nagasaki University Hospital, Nagasaki
Kojunkai Daido Clinic, Nagoya
National Hospital Organization Nagoya Medical Center, Nagoya
National Hospital Organization Nishiniigata Chuo Hospital, Niigata
National Hospital Organization Omuta Hospital, Omuta
National Hospital Organization Sagamihara National Hospital, Sagamihara
Saitama City Hospital, Saitama-shi
Kinki-chuo Chest Medical Center, Sakai
Hokkaido Medical Center, Sapporo Nishi-Ku
Tohoku Medical And Pharmaceutical University Hospital, Sendai
National Hospital Organization Nara Medical Center, Shichijō
Tokyo Shinagawa Hospital, Shinagawa-ku
National Center for Global Health and Medicine, Shinjuku
Keio University Hospital, Shinjuku-ku
Nagano Prefectural Shinshu Medical Center, Suzaka
National Hospital Organization Tokyo Medical Center, Tokyo
National Hospital Organization Tokyo National Hospital, Tokyo
National Hospital Organization Osaka Toneyama Medical Center, Toyonaka-shi
Toyota Kosei Hospital, Toyota
Toyota Memorial Hospital, Toyota-shi
National Hospital Organization Ehime Medical Center, Tōon
JRC Wakayama Medical Center, Wakayama
Shimonoseki City Hospital, Yamaguchi
Kanagawa Cardiovascular And Respiratory Center, Yokohama
The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Lead Sponsor
Janssen Pharmaceutical K.K.
INDUSTRY